UCB SA - Sales Analysis Snapshot

Business Description
This Report provides a comprehensive Sales & Margin summary analysis for UCB SA Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.

UCB SA(UCB). The Group's principal activity is to manufacture and market innovative pharmaceutical and biotechnological products. It includes research and drug manufacture for neurological disorders. The Group manufacures medicines for central nervous system disorders, allergies, respiratory diseases, cardiovascular diseases, inflammatory disorders, epilepsy, multiple sclerosis and cancer therapy. The research and development team works on antibody research. Their products include Keppra, Xyzal, Nootropi, Atarax, Lortab, Tussionex and Metadate. The Group operates mainly in Europe, the United States, Asia, Africa, Oceania and Middle East.

Not the Report you are looking for? Click here for more browsing options.

$600/yr | Annual Subscription | Premium Access to more than 150,000 company reports for $600/year**

$59.99/mo | Monthly Subscription | Premium Access to more than 150,000 company reports for $59.99/month**

$39.95 | ALL Reports on this company | Buy all reports for UCB SA

$24.95 | Single Sales Analysis Report | Buy this UCB SA Sales Analysis

Set Currency* Argentinian Pesos Australian Dollars Bermudan Dollars Brazilian Reals Canadian Dollars Chilean Pesos Chinese Renmimbi Colombian Pesos Czech Koruni Danish Kroner Dirham Egyptian Pounds Euro Hong Kong Dollars Hungarian Forints Icelandic Kronas Indian Rupees Indonesian Rupiahs Israel Shekels Japanese Yen Jordanian Dinars Korean Won Malaysian Ringgits Mexican Pesos Moroccan Dirhams New Zealand Dollars Norwegian Kroner Pakistan Rupees Peruvian New Sols Philippine Pesos Polish New Zlotys Pounds Sterling Russian Rubles Saudi Riyals Singapore Dollars Slovak Koruni South African Rands Sri Lanka Rupees Swedish Kronor Swiss Francs Taiwanese Dollars Thai Bahts Turkish Liras U.S. Dollars Venezuelan Bolivars Zimbabwe Dollars * If a currency is not selected, the report will be delivered in the local currency of the company ** Premium access limits users to 500 reports per month

Layout and Content of a Typical Report